Optivise Advisory Services’s Direxion HCM Tactical Enhanced US ETF HCMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-24,812
Closed -$873K 234
2026
Q1
$873K Sell
24,812
-19,188
-44% -$725K 0.53% 50
2025
Q4
$1.7M Sell
44,000
-11,570
-21% -$445K 0.98% 25
2025
Q3
$2.08M Buy
55,570
+33,870
+156% +$1.17M 1.24% 17
2025
Q2
$707K Buy
+21,700
New +$619K 0.36% 70
2025
Q1
Sell
-12,614
Closed -$455K 204
2024
Q4
$455K Buy
12,614
+5,625
+80% +$207K 0.25% 94
2024
Q3
$246K Sell
6,989
-22,159
-76% -$741K 0.13% 143
2024
Q2
$992K Buy
+29,148
New +$902K 0.54% 51

Other funds holding HCMT

Optivise Advisory Services's HCMT Position: Q2 2026 in Review

Optivise Advisory Services sold out of Direxion HCM Tactical Enhanced US ETF (HCMT) in Q2 2026, closing a stake of 24,812 shares — an estimated $873K sold.

Optivise Advisory Services first reported a position in HCMT in Q2 2024 and held it in 7 quarters. The position peaked at $2.08M in Q3 2025. 4 funds tracked by Wall St. Rank hold HCMT as of Q2 2026.

  • Optivise Advisory Services reported no remaining Direxion HCM Tactical Enhanced US ETF position as of Q2 2026 after selling out during the quarter.
  • Optivise Advisory Services sold 24,812 Direxion HCM Tactical Enhanced US ETF shares in Q2 2026, an estimated $873K.
  • Optivise Advisory Services first reported a position in Direxion HCM Tactical Enhanced US ETF in Q2 2024 and held it in 7 quarters.
  • Optivise Advisory Services's Direxion HCM Tactical Enhanced US ETF position peaked at $2.08M in Q3 2025.
  • 4 funds tracked by Wall St. Rank held Direxion HCM Tactical Enhanced US ETF as of Q2 2026.

Based on Optivise Advisory Services's 13F filing for Q2 2026, filed 13 Jul 2026.